aod9604 for weight loss AOD 9604: The Management Peptide - Vida Wellness AOD 9604 Peptide Therapy Victoria

Key Features Research Use Only

Clinical trial durations: Most obesity studies used daily dosing for 12 weeks

This product is supplied exclusively for laboratory research and must not be used for human or veterinary applications

Intramuscular therapy leads to more rapid improvement and should be considered in patients with severe deficiency or severe neurologic symptoms

Evidence-based dosing from 300-500mcg.

K-means clustering analysis of amplicon sequence variants by animal demonstrated that NNMTi-treated DIO mice switched to LD had a distinct microbiome pattern that was highlighted by decreased Erysipelatoclostridium and increased Lactobacillus relative abundances compared to vehicle counterparts